Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

LI KANG BIOMEDICAL Co. Ltd. (6242) Income Statement

LI KANG BIOMEDICAL Co. Ltd. Income Statement

Last quarter (Q2 2026), LI KANG BIOMEDICAL Co. Ltd.'s total revenue was NT$161.99M, a decrease of 1.59% from the same quarter last year. In Q2, LI KANG BIOMEDICAL Co. Ltd.'s net income was NT$24.58M. See LI KANG BIOMEDICAL Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 589.21MNT$ 565.51MNT$ 629.38MNT$ 684.25MNT$ 386.97M
NT$ 398.25MNT$ 386.10MNT$ 426.14MNT$ 388.58MNT$ 264.68M
NT$ 299.97MNT$ 296.08MNT$ 292.77MNT$ 251.22MNT$ 207.44M
Depreciation and AmortizationNT$ 8.79MNT$ 12.43MNT$ 11.74MNT$ 10.99MNT$ 12.89M
NT$ 113.22MNT$ 112.16MNT$ 151.37MNT$ 152.07MNT$ 76.83M
NT$ 98.28MNT$ 90.02MNT$ 133.37MNT$ 137.36MNT$ 63.94M
NT$ 5.77MNT$ 9.17MNT$ 5.77MNT$ 3.44MNT$ 6.24M
NT$ 104.05MNT$ 99.19MNT$ 139.14MNT$ 140.80MNT$ 63.48M
NT$ 83.82MNT$ 77.02MNT$ 110.99MNT$ 112.09MNT$ 51.44M
Per Share Metrics
Basic EPSNT$ 2.64NT$ 2.48NT$ 4.14NT$ 4.18NT$ 1.86
Diluted EPSNT$ 2.64NT$ 2.47NT$ 4.12NT$ 4.16NT$ 1.85
Weighted Average Shares Outstanding31.75M31.04M26.81M27.73M27.72M
Weighted Average Shares Outstanding (Diluted)31.75M31.19M26.96M27.88M27.85M

Currency in TWD

LI KANG BIOMEDICAL Co. Ltd. Earnings and Revenue History

0250M500M750M12 %14 %16 %18 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin